The Operation committee of Directors of Aspira Pathlab & Diagnostics Limited at its meeting held on November 27, 2019 at 6 PM has approved the allotment of 11,00,000 (Eleven Lakh) equity Shares of Rs. 10/- (Rupees Ten) each for cash at a price of Rs. 26/- (Rupees Twenty Six only) per share (including a premium of Rs. 16/- per share), the price has been calculated in accordance with the SEBI (ICDR) Regulations, 2018, aggregating to Rs. 2,86,00,000/- (Rupees 2 Crores 86 Lakhs) on preferential basis to Strategic Investors not forming part of Promoters Group of the Company.
Consequent to said allotment, the paid up equity share capital of the Company stand increased from Rs. 8,19,30,000 (Eight Crores Nineteen Lakhs Thirty Thousand) representing 81,93,000 equity shares of Rs. 10 each to Rs. 9,29,30,000 (Rupees 9 Crores Twenty Nine Lakhs Thirty Thousand) representing 92,93,000 equity shares of Rs. 10 each.